Advanced Malignancies

Also known as: Advanced Malignancy

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB12603AMG-2081Completed1
DB15639AMG-3371Completed1
DB12729ASP-30261Completed1
DB16412Adebrelimab1Recruiting2
DB05220Alisertib1Completed2
DB16640Almonertinib1Recruiting1
DB00112Bevacizumab1Completed2
DB00188Bortezomib1Completed1
DB16741Bortezomib D-mannitol1Completed1
DB12109CPI-6131Completed1
DB15082Cabiralizumab1Completed1
DB01101Capecitabine1Completed1
DB00958Carboplatin1Completed1
DB14707Cemiplimab1Completed1
DB14707Cemiplimab1Recruiting1
DB14707Cemiplimab1Withdrawn1
DB00531Cyclophosphamide1Completed1
DB08912Dabrafenib1Completed1
DB01248Docetaxel1Completed1
DB11714Durvalumab1Completed1
DB06302Glesatinib1Completed2
DB13023IPI-4931Terminated1
DB06186Ipilimumab1Recruiting1
DB01167Itraconazole1Recruiting1
DB16679Letaplimab1Active Not Recruiting1
DB16679Letaplimab1Completed1
DB15768MEDI06801Completed1
DB13061MLN80541Terminated1
DB15299Navtemadlin1Completed3
DB09035Nivolumab1Completed1
DB01229Paclitaxel1Completed1
DB14867Parsaclisib1Recruiting2
DB03010Patupilone1Completed4
DB03010Patupilone1Terminated1
DB09037Pembrolizumab1Terminated1
DB00642Pemetrexed1Completed1
DB12257Platinum1Recruiting1
DB01045Rifampicin1Recruiting1
DB00073Rituximab1Active Not Recruiting1
DB14765Rivoceranib1Terminated1
DB00020Sargramostim1Completed1
DB15765Sintilimab1Recruiting2
DB14892Spartalizumab1Completed1
DB12887Tazemetostat1Recruiting1
DB15043Toripalimab1Active Not Recruiting1
DB08911Trametinib1Completed2
DB08911Trametinib1Recruiting1
DB11771Tremelimumab1Completed1
DB04879Vatalanib1Completed1
DB05476WX-UK11Completed1
DB05014XL9991Completed1
DB00928Azacitidine1 / 2Terminated2
DB00188Bortezomib1 / 2Terminated1
DB01101Capecitabine1 / 2Unknown Status1
DB08889Carfilzomib1 / 2Terminated1
DB01262Decitabine1 / 2Active Not Recruiting1
DB01234Dexamethasone1 / 2Terminated1
DB00997Doxorubicin1 / 2Recruiting1
DB11717Epacadostat1 / 2Terminated2
DB01590Everolimus1 / 2Unknown Status1
DB00441Gemcitabine1 / 2Terminated1
DB16054INCB-0576431 / 2Terminated1
DB06186Ipilimumab1 / 2Active Not Recruiting1
DB06186Ipilimumab1 / 2Completed1
DB12154Itacitinib1 / 2Terminated1
DB00480Lenalidomide1 / 2Terminated1
DB09035Nivolumab1 / 2Active Not Recruiting1
DB09035Nivolumab1 / 2Completed1
DB01229Paclitaxel1 / 2Terminated1
DB14867Parsaclisib1 / 2Terminated1
DB09037Pembrolizumab1 / 2Recruiting2
DB09037Pembrolizumab1 / 2Terminated2
DB08910Pomalidomide1 / 2Terminated1
DB15185Rasdegafusp alfa1 / 2Completed1
DB06530Resiquimod1 / 2Completed1
DB16322Sabatolimab1 / 2Active Not Recruiting1
DB14892Spartalizumab1 / 2Active Not Recruiting1
DB11885Anlotinib2Completed1
DB09037Pembrolizumab2Recruiting1
DB15102Pemigatinib2Recruiting1
DB15766Retifanlimab2Recruiting1
DB06398Tanespimycin2Completed1
DB11945Avelumab3Recruiting1
DB06626Axitinib3Recruiting1
DB12267Brigatinib3Completed1
DB01101Capecitabine3Enrolling by Invitation1
DB08865Crizotinib3Completed1
DB00441Gemcitabine3Terminated1
DB16208Ivuxolimab3Recruiting1
DB14769Pamiparib3Enrolling by Invitation1
DB00642Pemetrexed3Enrolling by Invitation1
DB00642Pemetrexed3Recruiting1
DB11760Talazoparib3Recruiting1
DB00853Temozolomide3Enrolling by Invitation1
DB14922Tislelizumab3Enrolling by Invitation1
DB15113Utomilumab3Recruiting1
DB12267BrigatinibNot AvailableNo Longer Available1
DB05014XL999Not AvailableNo Longer Available1